TIDMGSK
RNS Number : 0510F
GlaxoSmithKline PLC
12 May 2017
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed
electronically and provided to an ris.
Date: 12 May 2017
Name of applicant: GlaxoSmithKline plc
------------------------------------------------------------ --------------------------------------------------------
Name of scheme: GlaxoSmithKline Share Option Plan - Ordinary Shares
------------------------------------------------------------ --------------------------------------------------------
Period of return: From: 1 November 2016 To: 30 April 2017
---------------------------------- ------------------------ ------------------------- ------ ---------------------
Balance of unallotted securities under scheme(s) from
previous return: 3,530,802
------------------------------------------------------------ --------------------------------------------------------
Plus: The amount by which the block scheme(s) has been
increased since the date of the last
return (if any increase has been applied for): 2,142,952(1)
------------------------------------------------------------ --------------------------------------------------------
Less: Number of securities issued/allotted under scheme(s)
during period (see LR3.5.7G): 1,569,653
------------------------------------------------------------ --------------------------------------------------------
Equals: Balance under scheme(s) not yet issued/allotted at
end of period: 4,104,101
------------------------------------------------------------ --------------------------------------------------------
(1) This figure includes an adjustment of +142,952 unallotted securities that were allotted
under the GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan but originally debited from
the balance for this Scheme.
----------------------------------------------------------------------------------------------------------------------
Name of contact: Victoria Whyte
------------------------------ ---------------
Telephone number of contact: 020 8047 5000
------------------------------ ---------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed
electronically and provided to an ris.
Date: 12 May 2017
Name of applicant: GlaxoSmithKline plc
------------------------------------------------------------------------ --------------------------------------------
Name of scheme: GlaxoSmithKline Share Option Plan - ADS
------------------------------------------------------------------------ --------------------------------------------
Period of return: From: 1 November 2016 To: 30 April 2017
---------------------------------------------- ------------------------ ------------------- ----- ----------------
Balance of unallotted securities under scheme(s) from previous return: 9,349,738
------------------------------------------------------------------------ --------------------------------------------
Plus: The amount by which the block scheme(s) has been increased since
the date of the last
return (if any increase has been applied for): 0
------------------------------------------------------------------------ --------------------------------------------
Less: Number of securities issued/allotted under scheme(s) during
period (see LR3.5.7G): 553,924
------------------------------------------------------------------------ --------------------------------------------
Equals: Balance under scheme(s) not yet issued/allotted at end of
period: 8,795,814
------------------------------------------------------------------------ --------------------------------------------
Name of contact: Victoria Whyte
------------------------------ ---------------
Telephone number of contact: 020 8047 5000
------------------------------ ---------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed
electronically and provided to an ris.
Date: 12 May 2017
Name of applicant: GlaxoSmithKline plc
-------------------------------------------------------------------------- ------------------------------------------
Name of scheme: Glaxo Wellcome UK Share Option Scheme
-------------------------------------------------------------------------- ------------------------------------------
Period of return: From: 1 November 2016 To: 30 April 2017
------------------------------------------------ ------------------------ ------------------ ----- ---------------
Balance of unallotted securities under scheme(s) from previous return: 5,119,750
-------------------------------------------------------------------------- ------------------------------------------
Plus: The amount by which the block scheme(s) has been increased since
the date of the last
return (if any increase has been applied for): 0
-------------------------------------------------------------------------- ------------------------------------------
Less: Number of securities issued/allotted under scheme(s) during period
(see LR3.5.7G): 0
-------------------------------------------------------------------------- ------------------------------------------
Equals: Balance under scheme(s) not yet issued/allotted at end of period: 5,119,750
-------------------------------------------------------------------------- ------------------------------------------
Name of contact: Victoria Whyte
------------------------------ ---------------
Telephone number of contact: 020 8047 5000
------------------------------ ---------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed
electronically and provided to an ris.
Date: 12 May 2017
Name of applicant: GlaxoSmithKline plc
--------------------------------------------------------------- -----------------------------------------------------
Name of scheme: Glaxo Wellcome International Share Option Scheme
--------------------------------------------------------------- -----------------------------------------------------
Period of return: From: 1 November 2016 To: 30 April 2017
------------------------------------- ------------------------ ------------------------ ----- --------------------
Balance of unallotted securities under scheme(s) from previous
return: 13,267,156
--------------------------------------------------------------- -----------------------------------------------------
Plus: The amount by which the block scheme(s) has been
increased since the date of the last
return (if any increase has been applied for): 0
--------------------------------------------------------------- -----------------------------------------------------
Less: Number of securities issued/allotted under scheme(s)
during period (see LR3.5.7G): 0
--------------------------------------------------------------- -----------------------------------------------------
Equals: Balance under scheme(s) not yet issued/allotted at end
of period: 13,267,156
--------------------------------------------------------------- -----------------------------------------------------
Name of contact: Victoria Whyte
------------------------------ ---------------
Telephone number of contact: 020 8047 5000
------------------------------ ---------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed
electronically and provided to an ris.
Date: 12 May 2017
Name of applicant: GlaxoSmithKline plc
-------------------------------------------------------------------------- ------------------------------------------
Name of scheme: Glaxo Wellcome 1999 Share Option Plan
-------------------------------------------------------------------------- ------------------------------------------
Period of return: From: 1 November 2016 To: 30 April 2017
------------------------------------------------ ------------------------ ------------------ ----- ---------------
Balance of unallotted securities under scheme(s) from previous return: 1,040,000
-------------------------------------------------------------------------- ------------------------------------------
Plus: The amount by which the block scheme(s) has been increased since
the date of the last
return (if any increase has been applied for): 0
-------------------------------------------------------------------------- ------------------------------------------
Less: Number of securities issued/allotted under scheme(s) during period
(see LR3.5.7G): 0
-------------------------------------------------------------------------- ------------------------------------------
Equals: Balance under scheme(s) not yet issued/allotted at end of period: 1,040,000
-------------------------------------------------------------------------- ------------------------------------------
Name of contact: Victoria Whyte
------------------------------ ---------------
Telephone number of contact: 020 8047 5000
------------------------------ ---------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed
electronically and provided to an ris.
Date: 12 May 2017
Name of applicant: GlaxoSmithKline plc
---------------------------------------------------- ----------------------------------------------------------------
Name of scheme: SmithKline Beecham 1989 Executive Share Option Plan - Approved
- Ordinary Shares
---------------------------------------------------- ----------------------------------------------------------------
Period of return: From: 1 November 2016 To: 30 April 2017
-------------------------- ------------------------ ------------------------- --------- --------------------------
Balance of unallotted securities under scheme(s)
from previous return: 163,606
---------------------------------------------------- ----------------------------------------------------------------
Plus: The amount by which the block scheme(s) has
been increased since the date of the last
return (if any increase has been applied for): 0
---------------------------------------------------- ----------------------------------------------------------------
Less: Number of securities issued/allotted under
scheme(s) during period (see LR3.5.7G): 0
---------------------------------------------------- ----------------------------------------------------------------
Equals: Balance under scheme(s) not yet
issued/allotted at end of period: 163,606
---------------------------------------------------- ----------------------------------------------------------------
Name of contact: Victoria Whyte
------------------------------ ---------------
Telephone number of contact: 020 8047 5000
------------------------------ ---------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed
electronically and provided to an ris.
Date: 12 May 2017
Name of applicant: GlaxoSmithKline plc
---------------------------------------------------- ----------------------------------------------------------------
Name of scheme: SmithKline Beecham 1989 Executive Share Option Plan -
Unapproved - ADS
---------------------------------------------------- ----------------------------------------------------------------
Period of return: From: 1 November 2016 To: 30 April 2017
-------------------------- ------------------------ -------------------------- -------- --------------------------
Balance of unallotted securities under scheme(s)
from previous return: 275,420
---------------------------------------------------- ----------------------------------------------------------------
Plus: The amount by which the block scheme(s) has
been increased since the date of the last
return (if any increase has been applied for): 0
---------------------------------------------------- ----------------------------------------------------------------
Less: Number of securities issued/allotted under
scheme(s) during period (see LR3.5.7G): 0
---------------------------------------------------- ----------------------------------------------------------------
Equals: Balance under scheme(s) not yet
issued/allotted at end of period: 275,420
---------------------------------------------------- ----------------------------------------------------------------
Name of contact: Victoria Whyte
------------------------------ ---------------
Telephone number of contact: 020 8047 5000
------------------------------ ---------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed
electronically and provided to an ris.
Date: 12 May 2017
Name of applicant: GlaxoSmithKline plc
---------------------------------------------------- ----------------------------------------------------------------
Name of scheme: SmithKline Beecham 1989 Executive Share Option Plan -
Unapproved - Ordinary
---------------------------------------------------- ----------------------------------------------------------------
Period of return: From: 1 November 2016 To: 30 April 2017
-------------------------- ------------------------ ------------------------- --------- --------------------------
Balance of unallotted securities under scheme(s)
from previous return: 100,000
---------------------------------------------------- ----------------------------------------------------------------
Plus: The amount by which the block scheme(s) has
been increased since the date of the last
return (if any increase has been applied for): 0
---------------------------------------------------- ----------------------------------------------------------------
Less: Number of securities issued/allotted under
scheme(s) during period (see LR3.5.7G): 0
---------------------------------------------------- ----------------------------------------------------------------
Equals: Balance under scheme(s) not yet
issued/allotted at end of period: 100,000
---------------------------------------------------- ----------------------------------------------------------------
Name of contact: Victoria Whyte
------------------------------ ---------------
Telephone number of contact: 020 8047 5000
------------------------------ ---------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed
electronically and provided to an ris.
Date: 12 May 2017
Name of applicant: GlaxoSmithKline plc
--------------------------------------------------- -----------------------------------------------------------------
Name of scheme: GlaxoSmithKline Savings Related Share Option Scheme
--------------------------------------------------- -----------------------------------------------------------------
Period of return: From: 1 November 2016 To: 30 April 2017
------------------------- ------------------------ ------------------------- ----------- -------------------------
Balance of unallotted securities under scheme(s)
from previous return: 2,742,626
--------------------------------------------------- -----------------------------------------------------------------
Plus: The amount by which the block scheme(s) has
been increased since the date of the last
return (if any increase has been applied for): 0
--------------------------------------------------- -----------------------------------------------------------------
Less: Number of securities issued/allotted under
scheme(s) during period (see LR3.5.7G): 0
--------------------------------------------------- -----------------------------------------------------------------
Equals: Balance under scheme(s) not yet 2,742,626 (the GlaxoSmithKline Savings Related Share Option
issued/allotted at end of period: Scheme has now expired. The balance
of 2,742,626 un-allotted shares under this Scheme has therefore
lapsed)
--------------------------------------------------- -----------------------------------------------------------------
Name of contact: Victoria Whyte
------------------------------ ---------------
Telephone number of contact: 020 8047 5000
------------------------------ ---------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed
electronically and provided to an ris.
Date: 12 May 2017
Name of applicant: GlaxoSmithKline plc
----------------------------------------------------------------------- ---------------------------------------------
Name of scheme: GlaxoSmithKline plc Share Save Plan 2012
----------------------------------------------------------------------- ---------------------------------------------
Period of return: From: 1 November 2016 To: 30 April 2017
--------------------------------------------- ------------------------ -------------------- ----- ----------------
Balance of unallotted securities under scheme(s) from previous return: 239,107
----------------------------------------------------------------------- ---------------------------------------------
Plus: The amount by which the block scheme(s) has been increased since
the date of the last
return (if any increase has been applied for): 2,000,000
----------------------------------------------------------------------- ---------------------------------------------
Less: Number of securities issued/allotted under scheme(s) during
period (see LR3.5.7G): 603,782
----------------------------------------------------------------------- ---------------------------------------------
Equals: Balance under scheme(s) not yet issued/allotted at end of
period: 1,635,325
----------------------------------------------------------------------- ---------------------------------------------
Name of contact: Victoria Whyte
------------------------------ ---------------
Telephone number of contact: 020 8047 5000
------------------------------ ---------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed
electronically and provided to an ris.
Date: 12 May 2017
Name of applicant: GlaxoSmithKline plc
------------------------------------------------------------ --------------------------------------------------------
Name of scheme: GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan
------------------------------------------------------------ --------------------------------------------------------
Period of return: From: 1 November 2016 To: 30 April 2017
---------------------------------- ------------------------ ------------------------- ------ ---------------------
Balance of unallotted securities under scheme(s) from
previous return: 0
------------------------------------------------------------ --------------------------------------------------------
Plus: The amount by which the block scheme(s) has been
increased since the date of the last
return (if any increase has been applied for): 600,000
------------------------------------------------------------ --------------------------------------------------------
Less: Number of securities issued/allotted under scheme(s)
during period (see LR3.5.7G): 399,929(1)
------------------------------------------------------------ --------------------------------------------------------
Equals: Balance under scheme(s) not yet issued/allotted at
end of period: 200,071
------------------------------------------------------------ --------------------------------------------------------
(1) This figure includes an adjustment of +142,952 allotted securities that were allotted
under this Scheme but originally debited from the balance for the block listing under the
GlaxoSmithKline Share Option Plan - Ordinary Shares.
----------------------------------------------------------------------------------------------------------------------
Name of contact: Victoria Whyte
------------------------------ ---------------
Telephone number of contact: 020 8047 5000
------------------------------ ---------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
BLRZMGMKKZZGNZM
(END) Dow Jones Newswires
May 12, 2017 11:26 ET (15:26 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2023 to Apr 2024
